Aurinia Pharmaceuticals  logo
Aurinia Pharmaceuticals AUPH
$ 8.49 3.09%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

Aurinia Pharmaceuticals Income Statement 2011-2024 | AUPH

Annual Income Statement Aurinia Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

874 M 1.29 B 1.59 B 1.66 B 1.63 B 539 M 424 M 113 M 64.3 M 97.7 M - - -

Shares

143 M 142 M 129 M 118 M 93 M 84.8 M 76.9 M 35.3 M 32.2 M 29.2 M - - -

Historical Prices

6.1 9.1 12.3 14 17.5 6.75 5.21 3.56 2.37 4.7 - - -

Net Income

-26.9 M -26 M -181 M -103 M -124 M -64.1 M -70.8 M -23.3 M -18.6 M -16.6 M -2.55 M -9.74 M -2.41 M

Revenue

45.1 M 28.4 M 45.6 M 50.1 M 318 K 463 K 420 K 173 K 235 K 278 K 949 K 6.16 M 928 K

Cost of Revenue

14.1 M 5.66 M 1.09 M - - - - - - - - - -

Gross Profit

- - - - -52.5 M -40.9 M -33.5 M -14.4 M -15.8 M -8.87 M -986 K 602 K 742 K

Operating Income

-29.7 M -28.1 M -181 M -104 M -90.9 M -55.2 M - - - - - - -

Interest Expense

2.78 M - - - - - - - - - - - -

EBITDA

-18 M -25.4 M -178 M -103 M -74.7 M -54.6 M -45.6 M -21.3 M -22 M -15.8 M -3.22 M -4.62 M -5.48 M

Operating Expenses

74.8 M 56.5 M 56.1 M 97.3 M 23.7 M 15.2 M 13.6 M 8.45 M 7.82 M 8.41 M 3.04 M 6.07 M 7.18 M

General and Administrative Expenses

195 M 196 M 174 M 97.3 M 22.2 M 13.7 M 12.1 M 6.97 M 6.26 M 6.89 M 2.23 M 3.9 M 2.74 M

All numbers in USD currency

Quarterly Income Statement Aurinia Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

143 M 143 M 144 M 144 M 143 M 143 M 143 M 142 M 142 M 142 M 142 M 142 M 128 M 128 M 127 M 127 M 122 M 113 M 112 M 112 M - - - 85.5 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

14.4 M 722 K -10.7 M - -13.4 M -11.5 M -26.2 M - -8.99 M -35.5 M -37.6 M -33.3 M -50.3 M -47 M -50.4 M -8.07 M -42.1 M -26.5 M -25.9 M -34.5 M -23.5 M -16.4 M -14.1 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

67.8 M 57.2 M 50.3 M - 54.5 M 41.5 M 34.4 M - 55.8 M 28.2 M 21.6 M 23.4 M 14.7 M 6.62 M 914 K 50 M 29 K 29 K 30 K 29 K 230 K 29 K 30 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

6.04 M 8.91 M 7.75 M - 6.77 M 1.56 M 421 K - 2.45 M 1.6 M 256 K - 254 K 308 K 48 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

11.7 M -1.51 M -13.3 M - -16.3 M -16.2 M -29.6 M - -9.5 M -36 M -37.9 M -32.7 M -50.4 M -47.1 M -50.5 M -8.05 M -42.3 M -26.9 M -27.1 M -34.8 M -24.1 M -17.1 M -14.9 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

- 1.2 M 1.28 M - 1.4 M 65 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

11.9 M -1.31 M -8.41 M - -15.8 M -15.7 M -28.9 M - -9 M -35.5 M -37.2 M -32.7 M -48.3 M -46.9 M -49.9 M -8.05 M -42.3 M -26.9 M -27 M -34.8 M -24.1 M -17.1 M -14.9 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

- - - - - - - - - - - 56.1 M 65 M 53.8 M 51.5 M 58.1 M 42.3 M 26.9 M 27.1 M 34.9 M 24.3 M 17.2 M 14.9 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

42.4 M 44.9 M 47.7 M - 47.8 M 47.1 M 50.1 M - 52.2 M 51.5 M 45.2 M - 44.6 M 43.8 M 39.8 M - 30.7 M 15.4 M 11.1 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency